article thumbnail

Boston Scientific to Acquire Axonics for $3.7 Billion

JD Supra: Mergers

Boston Scientific Corporation (“Boston Scientific”) announced on January 8 that it has entered into a definitive agreement to acquire Axonics, Inc. Morgan Healthcare Conference in San Francisco, which also saw the announcement of major acquisitions by large players in the pharmaceutical space. By: Knobbe Martens

article thumbnail

DOJ Announces New Safe Harbor Policy for Voluntary Self-Disclosure in M&A

JD Supra: Mergers

The Department of Justice continues to make clear that one of its principal corporate enforcement priorities is encouraging companies to voluntarily self-disclose misconduct.

M&A 167
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Shareholders vs. Stakeholders - Understanding Corporate Responsibilities

Peak Frameworks

In the world of finance and corporate responsibility, two terms frequently arise: "stakeholder" and "shareholder." A shareholder is an individual or entity that owns shares or stock in a corporation. What is a Shareholder? By virtue of their ownership, they possess a direct financial interest in the company's success.

article thumbnail

Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company

Global Newswire by Notified: M&A

Ltd (“IPK”) (the “Transaction”).

article thumbnail

From Mergers to Acquisitions: How to Successfully Execute a Corporate Restructuring Plan

Devensoft

Corporate restructuring can be a game-changer for any organization, whether it’s a merger, acquisition, or any other strategic move. We, at Devensoft, help companies with their end-to-end M&A and have worked with several clients in the corporate sector to navigate this complex process.

article thumbnail

Virbac to take a leading position in Japan through the acquisition of Sasaeah

Global Newswire by Notified: M&A

Formed through the combination of two legacy animal health providers (Fujita Pharmaceutical Co. under the stewardship of ORIX Corporation, Sasaeah generates annual revenues of about €75 million, of which 50% from vaccines. and Kyoto Biken Laboratories Inc.)

article thumbnail

Cannabis Market to Hit USD 444.34 Billion by 2030 | At 34.03% CAGR

Global Newswire by Notified: M&A

Key companies covered in cannabis market are Aurora Cannabis, Aphria Inc, Canopy Growth Corporation, MedReleaf Corp., GW Pharmaceuticals. Tilray, and others Key companies covered in cannabis market are Aurora Cannabis, Aphria Inc, Canopy Growth Corporation, MedReleaf Corp., GW Pharmaceuticals. Cronos Group Inc.,